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Abstract— Recent SARS-CoV-2 pandemic leading to a
rapidly increasing number of hospitalizations enforced reeval-
uation of wound management strategies.
The optimal treatment strategy for patients with chronic
wounds and those recovering from emergency and urgent onco-
logical surgery should aim to minimize the number of hospital
admissions, as well as the number of surgical procedures and
decrease the length of stay to disburden the hospital staff and
to minimize viral infection risk.
One of the potential solutions that could help to achieve these
goals may be the extensive and early use of NPWT devices in
the prevention of wound healing complications.
Single-use NPWT devices are helpful in outpatient wound
treatment and SSI prevention (ciNPWT) allowing to minimize
in-person visits to the health care center while still providing the
best possible wound-care. Stationary NPWT should be used in
deep SSI and perioperative wound healing disorders as soon as
possible. Patient’s education and telemedical support with visual
wound healing monitoring and video conversations have the
potential to minimize the number of unnecessary in-person visits
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in patients with wounds and therefore substantially increase the
level of care.
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Introduction
THE epidemiological situation in the world caused bythe SARS-CoV-2 virus leads to a rapidly increasing
number of hospitalizations. Hospital wards are being con-
verted into dedicated COVID-19 wards what brings many
sudden changes in the system and treatment strategy. There
are many recommended procedures for the prevention of
surgical site infections (SSI), but only a few deals with the
treatment of complications, and especially patients in home
care. The current general strategy is to minimize the number
of nonessential hospitalizations for three main reasons:
1) providing intensive care units the capacity for COVID-
19 patients requiring intensive care;
2) preserving medical staff due to the shortage of medical
personnel
3) reducing the risk of infection for hospitalized patients
and medical staff
SSI symptoms after abdominal and chest injury surgery
may camouflage asymptomatic SARS-CoV-2 infection espe-
cially in the era of COVID-19 pandemic.1 Therefore min-
imizing hospitalization time may decrease the risk of viral
transmission in post-surgical patients.
General strategy
The optimal treatment strategy for patients with chronic
wounds and those recovering from emergency and urgent
oncological surgery should aim to minimize the number of
hospital admissions because of the surgical reasons described
in detail in the ERAS protocol,2 as well as the number of
surgical procedures. On the other hand, the hospitalization
time should be optimized to be as short as possible to
Medigent.org cb DOI: 10.18487/npwtj.v7i2.58
BANASIEWICZ et al. : NPWT DEVICES DURING THE COVID-19 PANDEMIC 5
Figure 1. The treatment strategy in three most common settings (columns) during the SARS-CoV-2 pandemic.
disburden the hospital staff and to minimize viral infec-
tion risk. One of the potential solutions that could help to
achieve these goals may be the extensive and early use of
Negative Pressure Wound Therapy (NPWT) devices in the
prevention of wound healing complications3 (mainly surgical
site infections — SSI4 or wound dehiscence), particularly
among higher-risk patients,5 those with complex incisions
with ort without prosthetic devices underlying the closed
incision.6–8 Li et al. proved that patients undergoing NPWT
after open abdominal surgery had SSI less frequently9 and
the formation of enteroatmospheric fistulae were also less
frequent in patients receiving.10
The relative liberal use of ciNPWT, may well be advanta-
geous for patients who are discharged as an inpatient earlier
than normal to free up capacity for acute COVID beds may
continue to receive good quality healthcare at home.11
This strategy may be highly important in a group of
patients undergoing urgent surgery or those with wounds
classified as contaminated. Based on recent studies, ciNPWT
significantly reduced the incidence rate of SSI in colorec-
tal, inflammatory bowel disease patients or groin vascular
surgery, as well as other disciplines such as Orthopaedic
and Plastic Surgery.12–14 NPWT could also be used more
extensively in tearly wound healing complications and wound
infections allowing a rapid, safe and effective inpatient dis-
charge. Prevention of SSI using ciNPWT (closed incision
NPWT) can lead to reduce the incidence of SSI, and also the
number of wound dressing changes15 (disburdening medical
staff, and minimizing contact with the patients). In septic
and complicated wounds, iNPWT (instillation NPWT) should
be more commonly applied. It was stated that the utility
of NPWT with instillation in complicated and non-healed
wounds was associated with a significant decrease in bacterial
overload reduction, time to wound closure and hospital dis-
charge.16 The principles of the treatment strategy are shown
on (Fig. 1).
NPWT can be used as soon as possible in wound healing
disturbances, especially those caused by infections. The
stationary device initially applied in hospitalized patients
can be continued in an ambulatory setting using a single-
use portable NPWT device. Single-use ciNPWT devices are
widely available on the market, intuitive, and easy to use.
The education of patients on how to remove a vacuum wound
dressing, in selected well-collaborating patients, can be very
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Figure 2. Proposed patient flow in a surgery hospital department.
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helpful and is essential when dealing with the dressing’s seal
leak during NPWT at home. Current evidence support the
home use of single-use NPWT (sNPWT) due to high patient-
satisfaction.17
Dowset et al. provided data on the clinical and economic
benefit of sNPWT in patients with chronic wounds allowing
to free up medical staff.18 Similar benefits have been shown
in the closed incision groups also.7, 19 The same principles
will apply to acute and surgical wounds during the COVID-
19 pandemic. This is especially important as there is evidence
that the effectiveness of sNPWT is similar in inpatient and
outpatient setting.20
The telemedical support for patients should lead to a
good postoperative wound control and can be used in an
outpatient treatment manner. Options with the possibility of
digital photography transfer are preferable. The optimal flow
of patients (out- and inpatients) is shown on (Fig. 2). The
main problems associated with the wound healing process
are listed below.
1. Problem: Management of outpatients with wounds
Goal: In patients with acute or chronic wounds the ambu-
latory treatment should be as effective as inpatient therapy
while reducing the number of in-person visits. Solution
(using NPWT):
1) The prophylactic21 use of single-use NPWT devices
if possible (reducing the number of wound dressings
changes, making treatment more effective) is advised.
2) In chronic venous leg ulcers NPWT should be com-
bined with compression therapy (using either bandag-
ing or compression stockings.22
3) Patients should be educated on minimizing the risk of
SARS-CoV-2 infection.
4) Telemedical support23 for patients during wound dress-
ing self-removal, dressing leaks, and, in selected cases,
in wound dressing changes is essential, with secure
video conversations as the gold standard.
2. Problem: Management of surgical patients (emergency and
urgent oncologic procedures) and SSI
Goals:
1) reduction of the SSI severity and frequency;
2) effective treatment of SSI;
3) avoidance of reoperations;
4) early discharge
Solution (using NPWT):
1) NPWT in all patients with complicated wounds, (e.g.
open abdomen,24 open fractures25), and ciNPWT in high-
risk patients for SSI, complex wounds and those associated
with a prosthesis are recommended (if available and possible
also in other patients); In order to minimize the costs of the
ciNPWT — alternative low-cost methods can be advised.26
2), 3) NPWT therapy should be introduced as soon as
possible in SSI (according to CDC classification:27 superficial
incisional SSI — single-use NPWT, stationary NPWT; deep
incisional SSI — stationary NPWT (consider instillation —
iNPWT); organ or space SSI — stationary NPWT (consider
instillation — iNPWT)
4) optimal wound healing should be provided to patients
with a higher risk of developing SSI (obesity or cachexia,
ASA 3 and 4, immunosupression, steroids, cigarette smoking,
comorbidities) by using an effective wound dressing suitable
for discharge — single-use NPWT combined with patient
education on wound dressing self-removal and, in selected
cases, in wound dressing changes. Telemedical support for
theses patients is essential to minimize in-person visits.23
Patient should be educated that in case of skin infection
presenting with pain, heat, redness, swelling or purulent
discharge at the incision site, they should seek immediate
consultation via telemedical support.
Even if lower risk for SSI is calculated, ciNPWT should
be considered as first line treatment option for wound
management. Such management may reduce the risk for
developing SSI to the minimum and prevent readmission or
complications during outpatient care.
In cases where patients would not be able to follow
telemedical guidance on wound dressing changes or in more
complicated dressing requiring in-person visits, it is highly
advisable to prolong the intervals between dressing changes
in order to minimize the number of in-person visits. NPWT
is highly suitable to prolong dressing change intervals17 and
can be recommended to achieve this.
3. Problem: Follow-up surveillance of outpatients after
surgery
Goal: To facilitate wound follow-up with detection of SSI
after discharge, reduce the number of in-person visits, and
provide the most effective wound healing support. Solution
(using NPWT):
1) The use of single pocket NPWT devices if possible
(reducing the number of wound dressings changes,
making(e) treatment more effective) is advised.
2) Patients should be educated on minimizing the risk of
SARS-CoV-2 infection education.,
3) Telemedical support for patients during wound dressing
self-removal and, in selected cases, in wound dressing
changes with secure video conversations is essential.
Conclusion
In order to reduce the risk of viral transmission, early
treatment of wound healing complications, and reducing the
risk of SSI using NPWT is advisable, especially during
the SARS-CoV-2 pandemic. NPWT should be considered in
wound healing disorders and their prevention as the therapy
can effectively decrease the number of complications, reduce
the number of surgical interventions, decrease the length of
stay, reduce the number of wound dressings changes, reduce
the number of contacts between patients and medical staff
and disburden the already decompressed healthcare system.
Single-use NPWT devices are helpful in outpatient wound
treatment and SSI prevention (ciNPWT) allowing to min-
imize in-person visits to the health care center while still
providing the best possible wound-care. Stationary NPWT
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should be used in deep SSI and perioperative wound heal-
ing disorders as soon as possible. Patient’s education and
telemedical support with visual wound healing monitoring
and video conversations have the potential to minimize the
number of unnecessary in-person visits in patients with
wounds and therefore substantially increase the level of care.
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